CID 172997

Lixivaptan

Structural Information

Molecular Formula
C27H21ClFN3O2
SMILES
CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl
InChI
InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33)
InChIKey
PPHTXRNHTVLQED-UHFFFAOYSA-N
Compound name
N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

84
References

1178
Patents

473.13065 Da
Monoisotopic Mass

4.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 474.13793 212.1
[M+Na]+ 496.11987 225.2
[M+NH4]+ 491.16447 218.2
[M+K]+ 512.09381 219.0
[M-H]- 472.12337 216.6
[M+Na-2H]- 494.10532 218.2
[M]+ 473.13010 215.5
[M]- 473.13120 215.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe